COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

Role of Anticoagulants and Antiplatelet Agents for Patients With COV…

CHEST 2022 Coverage

V. Balasubramanian

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Pulmonary Embolism: Role of Catheter-Based Interventions

Baylor College of Medicine

P. Loyalka

Updates in Thrombosis and Anticoagulation

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

Management of Simultaneous Venous and Arterial Thromboembolic Disease

Scripps Health

J. May

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

Current Review of Benign Hematology and Coagulopathy

Indy Hematology Review

C. Kessler

Perioperative Considerations for Anticoagulation With Mechanical Dev…

James Douketis

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ACC 2024 Insights

J. Johnson

Venous Thromboembolism Prophylaxis in Newly Diagnosed MM

Vanderbilt University Medical Center (VUMC)

M. Baljevic

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Prevent…

Robert McBane

ADT for Prostate Cancer and Cardiovascular Health Considerations

Andrew Hahn

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Total Health

I. Rhea